Real-time enrollment status for this breast neoplasms clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:37 AM UTC
| NCT Number | NCT07173751 |
| Recruiting Status | Recruiting |
| Condition | Breast Neoplasms |
| Phase | Clinical Trial |
| Target Enrollment | 558 participants |
| Active Locations | 47 sites in the US |
| Sponsor | BioNTech SE |
| Last Updated on CT.gov | June 25, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT07173751 is currently recruiting participants. This clinical trial study for breast neoplasms is actively seeking new participants at 47 locations across the United States. The study is sponsored by BioNTech SE. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07173751 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 47 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07173751 was last updated 2 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.